Evidence map›Paper›PMID 30275110›Full record

ReviewBlood2018

A synthesis approach of mouse studies to identify genes and proteins in arterial thrombosis and bleeding.

Constance C F M J Baaten, Stuart Meacham, Susanne M de Witt, Marion A H Feijge, David J Adams, Jan-Willem N Akkerman, Judith M E M Cosemans, Luigi Grassi, Steve Jupe, Myrto Kostadima and 9 more

Open access · bronzeAbstract readReview
In one paragraph

Review in Blood, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Ultra-high-throughput CaiScience · 2022
    Article
  7. Article
  8. Platelet GPVI (Glycoprotein VI) and Thrombotic Complications in the Venous System.Arteriosclerosis, thrombosis, and vascular biology · 2021
    Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Resolution of Deep Venous Thrombosis: Proposed Immune Paradigms.International journal of molecular sciences · 2020
    Review
  14. Review
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors at 10 institutions in 3 countries.

Constance C F M J BaatenDepartment of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, The Netherlands.
Stuart MeachamDepartment of Haematology, University of Cambridge and NHS Blood and Transplant, Cambridge, United Kingdom.
Susanne M de WittDepartment of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, The Netherlands.
Marion A H FeijgeDepartment of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, The Netherlands.
David J AdamsWellcome Sanger Institute, Hinxton, Cambridge, United Kingdom.
Jan-Willem N AkkermanLaboratory of Clinical Chemistry and Haematology, University Medical Centre Utrecht, Utrecht, The Netherlands.
Judith M E M CosemansDepartment of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, The Netherlands.
Luigi GrassiDepartment of Haematology, University of Cambridge and NHS Blood and Transplant, Cambridge, United Kingdom.
Steve JupeEMBL-European Bioinformatics Institute, Cambridge, United Kingdom.
Myrto KostadimaDepartment of Haematology, University of Cambridge and NHS Blood and Transplant, Cambridge, United Kingdom.
Nadine J A MattheijDepartment of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, The Netherlands.
Martin H PrinsDepartment of Clinical Epidemiology, Maastricht University Medical Centre, Maastricht, The Netherlands.
Ramiro Ramirez-SolisWellcome Sanger Institute, Hinxton, Cambridge, United Kingdom.
Oliver SoehnleinInstitute for Cardiovascular Prevention (IPEK), Ludwig Maximilians University, Munich, Germany.
Frauke SwieringaDepartment of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, The Netherlands.
Christian WeberInstitute for Cardiovascular Prevention (IPEK), Ludwig Maximilians University, Munich, Germany.
Jacqueline K WhiteWellcome Sanger Institute, Hinxton, Cambridge, United Kingdom.
Willem H OuwehandDepartment of Haematology, University of Cambridge and NHS Blood and Transplant, Cambridge, United Kingdom.
Johan W M HeemskerkDepartment of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, The Netherlands.
Maastricht University · NLWellcome Sanger Institute · GBUniversity of Cambridge · GBEuropean Bioinformatics Institute · GBLudwig-Maximilians-Universität München · DEMaastricht University Medical Centre · NLNHS Blood and Transplant · GBUniversitätsklinikum Aachen · DEUniversity Medical Center Utrecht · NLUniversity of Amsterdam · NL

Funding

Reactome - CoreU41HG003751 · NHGRI · ONTARIO INSTITUTE FOR CANCER RESEARCH · PI DEUSTACHIO, PETER G, HERMJAKOB, HENNING · 2012 to 2021
$14.5M
British Heart Foundation RG/09/12/28096NHGRI NIH HHS U41 HG003751
6 · The paper itself

Abstract

Antithrombotic therapies reduce cardiovascular diseases by preventing arterial thrombosis and thromboembolism, but at expense of increased bleeding risks. Arterial thrombosis studies using genetically modified mice have been invaluable for identification of new molecular targets. Because of low sample sizes and heterogeneity in approaches or methodologies, a formal meta-analysis to compare studies of mice with single-gene defects encountered major limitations. To overcome these, we developed a novel synthesis approach to quantitatively scale 1514 published studies of arterial thrombus formation (in vivo and in vitro), thromboembolism, and tail-bleeding of genetically modified mice. Using a newly defined consistency parameter (CP), indicating the strength of published data, comparisons were made of 431 mouse genes, of which 17 consistently contributed to thrombus formation without affecting hemostasis. Ranking analysis indicated high correlations between collagen-dependent thrombosis models in vivo (FeCl

Indexed as

HemorrhageThrombosisAnimalsDisease Models, AnimalHumansMiceMice, Knockout

Identifiers

PMID30275110
PMCPMC6293874
OpenAlexW2895685061

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.